SCHEMBL12818239

SCHEMBL12818239

Cc1nc2ccc(S(=O)(=O)N3CCSc4ccc(-c5ncc(C#N)s5)cc43)cc2s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 3/20 0.41
▸ PKLR P30613 1/20 0.41
▸ KDM2B Q8NHM5 1/20 0.40
▸ LMNA P02545 9/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ HPGD P15428 4/20 0.36
▸ MAPT P10636 3/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ SMN1; SMN2 Q16637 7/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ GLA P06280 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ RUNX1 Q01196 1/20 0.35
▸ CBFB Q13951 1/20 0.35
▸ CPT2 P23786 1/20 0.35
▸ CPT1A P50416 1/20 0.35
▸ CPT1B Q92523 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12818610 0.87 PKM (0.41) PKMPKLRKDM2BLMNAALDH1A1
SCHEMBL12818673 0.87 PKM (0.41) PKMPKLRKDM2BLMNAALDH1A1
SCHEMBL12818410 0.87 PKM (0.41) PKMPKLRKDM2BLMNAALDH1A1
SCHEMBL12818019 0.86 PKM (0.42) PKMPKLRKDM2BLMNAALDH1A1
SCHEMBL12818716 0.86 PKM (0.43) PKMPKLRKDM2BLMNAALDH1A1
SCHEMBL12817702 0.86 PKM (0.41) PKMPKLRKDM2BLMNAALDH1A1
SCHEMBL12818622 0.85 PKM (0.40) PKMPKLRKDM2BLMNAALDH1A1
SCHEMBL12818524 0.84 PKM (0.44) PKMPKLRKDM2BLMNAALDH1A1
SCHEMBL12819198 0.84 LMNA (0.41) PKMPKLRKDM2BLMNAALDH1A1
SCHEMBL12817711 0.84 GCK (0.36) ALDH1A1HPGDMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO claimed
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback